Magar, S.D. and Pawar, P.Y. 2022. In silico ADMET screening & molecular docking of some 1-(5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl) ethanone derivatives to be developed as triple mutant T790M/C797S EGFR inhibitors. International journal of health sciences. 6, S3 (Jun. 2022), 10432–10451. DOI:https://doi.org/10.53730/ijhs.v6nS3.9448.